BF Biosciences Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	491.4	447.15	385.41	149.05	306.98	607.99
Depreciation & Amortization	243.56	191.92	35.57	33.78	28	23
Other Amortization	1.98	1.69	0.55	0.55	-	-
Loss (Gain) From Sale of Assets	-2.8	-2.79	-2.13	-1.06	-	-
Loss (Gain) From Sale of Investments	-58.12	-27.3	-0.21	-8.93	-	-
Other Operating Activities	15.35	44.33	305.49	32.12	-156.98	-60.99
Change in Accounts Receivable	-96.24	20.37	-110.82	-41.1	-	-
Change in Inventory	-653.66	-846.4	-41.57	-445.69	-	-
Change in Accounts Payable	271.82	472.43	196.75	-5.94	-	-
Change in Unearned Revenue	-5.99	-5.27	19.75	-17.78	-	-
Change in Other Net Operating Assets	83.78	3.66	-124.09	108.94	-	-
Operating Cash Flow	291.08	299.79	664.7	-196.07	178	570
Operating Cash Flow Growth	-38.38%	-54.90%	-	-	-68.77%	-
Capital Expenditures	-296.52	-329.49	-143.13	-1,968	-1,130	-941
Sale of Property, Plant & Equipment	3.87	3.86	4.4	1.06	-	-
Sale (Purchase) of Intangibles	-	-	-	-1.66	-	-
Investment in Securities	-1,200	-1,100	108.58	1,161	-	-
Other Investing Activities	95.27	91	16.34	83.4	-333	-399
Investing Cash Flow	-1,397	-1,335	-13.81	-724.44	-1,463	-1,340
Long-Term Debt Issued	-	93.55	-	811.02	-	-
Long-Term Debt Repaid	-	-436.19	-321.36	-50.5	-	-
Net Debt Issued (Repaid)	-379.42	-342.64	-321.36	760.52	-	-
Issuance of Common Stock	203.2	1,855	-	-	-	-
Other Financing Activities	-108.89	-112.25	-161.52	-120.28	925	1,162
Financing Cash Flow	-285.11	1,400	-482.88	640.24	925	1,162
Miscellaneous Cash Flow Adjustments	-	-	-	-	1	1
Net Cash Flow	-1,391	365.04	168.02	-280.27	-359	393
Free Cash Flow	-5.44	-29.71	521.57	-2,164	-952	-371
Free Cash Flow Margin	-0.08%	-0.51%	14.26%	-119.61%	-62.60%	-21.14%
Free Cash Flow Per Share	-0.06	-0.37	8.23	-34.17	-15.03	-5.86
Cash Interest Paid	108.89	112.25	161.52	120.28	-	-
Cash Income Tax Paid	347.15	279.05	51.39	73.4	-	-
Levered Free Cash Flow	-2,130	-255.5	313.25	-2,306	-834	-670.45
Unlevered Free Cash Flow	-2,064	-183.39	401.52	-2,306	-792.99	-654.66
Change in Working Capital	-400.29	-355.21	-59.98	-401.58	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.